These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 24258355)

  • 1. Important and relevant symptoms including pain concerns in hepatocellular carcinoma (HCC): a patient interview study.
    Kaiser K; Mallick R; Butt Z; Mulcahy MF; Benson AB; Cella D
    Support Care Cancer; 2014 Apr; 22(4):919-26. PubMed ID: 24258355
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Status of inflammation in relation to health related quality of life in hepatocellular carcinoma patients.
    Li L; Chan SL; Mo F; Hui EP; Koh J; Chan AK; Tang NL; Chu CM; Hui J; Lee KF; Yu S; Yeo W
    Qual Life Res; 2019 Sep; 28(9):2597-2607. PubMed ID: 31037590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic values of EORTC QLQ-C30 and QLQ-HCC18 index-scores in patients with hepatocellular carcinoma - clinical application of health-related quality-of-life data.
    Li L; Mo FK; Chan SL; Hui EP; Tang NS; Koh J; Leung LK; Poon AN; Hui J; Chu CM; Lee KF; Ma BB; Lai PB; Chan AT; Yu SC; Yeo W
    BMC Cancer; 2017 Jan; 17(1):8. PubMed ID: 28052758
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychometric properties of a brief, clinically relevant measure of pain in patients with hepatocellular carcinoma.
    Butt Z; Lai JS; Beaumont JL; Kaiser K; Mallick R; Cella D; Steel JL
    Qual Life Res; 2014 Nov; 23(9):2447-55. PubMed ID: 24748017
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Symptom concerns and quality of life in hepatobiliary cancers.
    Sun V; Ferrell B; Juarez G; Wagman LD; Yen Y; Chung V
    Oncol Nurs Forum; 2008 May; 35(3):E45-52. PubMed ID: 18467279
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes with atezolizumab plus bevacizumab versus sorafenib in patients with unresectable hepatocellular carcinoma (IMbrave150): an open-label, randomised, phase 3 trial.
    Galle PR; Finn RS; Qin S; Ikeda M; Zhu AX; Kim TY; Kudo M; Breder V; Merle P; Kaseb A; Li D; Mulla S; Verret W; Xu DZ; Hernandez S; Ding B; Liu J; Huang C; Lim HY; Cheng AL; Ducreux M
    Lancet Oncol; 2021 Jul; 22(7):991-1001. PubMed ID: 34051880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association of liver function and quality of life of patients with liver cancer.
    Li L; Mo F; Hui EP; Chan SL; Koh J; Tang NLS; Yu SCH; Yeo W
    BMC Gastroenterol; 2019 May; 19(1):66. PubMed ID: 31046687
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prospective Longitudinal Assessment of Quality of Life for Liver Cancer Patients Treated With Stereotactic Body Radiation Therapy.
    Klein J; Dawson LA; Jiang H; Kim J; Dinniwell R; Brierley J; Wong R; Lockwood G; Ringash J
    Int J Radiat Oncol Biol Phys; 2015 Sep; 93(1):16-25. PubMed ID: 26279020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of a questionnaire module to supplement the EORTC QLQ-C30 to assess quality of life in patients with hepatocellular carcinoma, the EORTC QLQ-HCC18.
    Blazeby JM; Currie E; Zee BC; Chie WC; Poon RT; Garden OJ;
    Eur J Cancer; 2004 Nov; 40(16):2439-44. PubMed ID: 15519517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Psychopathological profile and health-related quality of life (HRQOL) in patients with hepatocellular carcinoma (HCC) and cirrhosis.
    Palmieri VO; Santovito D; Margari F; Lozupone M; Minerva F; Di Gennaro C; Todarello O; Palasciano G
    Clin Exp Med; 2015 Feb; 15(1):65-72. PubMed ID: 24323278
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Review of Studies Assessing the Health-Related Quality of Life of Hepatocellular Carcinoma Patients from 2009 to 2018.
    Kang D; Shim S; Cho J; Lim HK
    Korean J Radiol; 2020 Jun; 21(6):633-646. PubMed ID: 32410403
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Health-related quality-of-life impact of pembrolizumab versus best supportive care in previously systemically treated patients with advanced hepatocellular carcinoma: KEYNOTE-240.
    Ryoo BY; Merle P; Kulkarni AS; Cheng AL; Bouattour M; Lim HY; Breder V; Edeline J; Chao Y; Ogasawara S; Yau T; Garrido M; Chan SL; Daniele B; Norquist JM; Chen E; Siegel AB; Zhu AX; Finn RS; Kudo M
    Cancer; 2021 Mar; 127(6):865-874. PubMed ID: 33231873
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding the patient experience in hepatocellular carcinoma: a qualitative patient interview study.
    Patel N; Maher J; Lie X; Gwaltney C; Barzi A; Karwal M; Macarulla T; Sun HC; Trojan J; Meyers O; Workman C; Morgan S; Negro A; Cohen G
    Qual Life Res; 2022 Feb; 31(2):473-485. PubMed ID: 34115280
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Health-Related Quality of Life in Patients with Hepatocellular Carcinoma Treated with Initial Transarterial Chemoembolization.
    Hinrichs JB; Hasdemir DB; Nordlohne M; Schweitzer N; Wacker F; Vogel A; Kirstein MM; Marquardt S; Rodt T
    Cardiovasc Intervent Radiol; 2017 Oct; 40(10):1559-1566. PubMed ID: 28488104
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A Prospective Evaluation of the Reliability and Utility of Quality of Life Measures in Patients With Hepatocellular Carcinoma.
    Kim GA; Kim HI; Chang S; An J; Lee D; Lee HC; Han S; Shim JH
    Am J Clin Oncol; 2019 Jul; 42(7):555-563. PubMed ID: 31135382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Value of quality of life analysis in liver cancer: A clinician's perspective.
    Li L; Yeo W
    World J Hepatol; 2017 Jul; 9(20):867-883. PubMed ID: 28804570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
    Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
    Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II trial of palliative radiotherapy for hepatocellular carcinoma and liver metastases.
    Soliman H; Ringash J; Jiang H; Singh K; Kim J; Dinniwell R; Brade A; Wong R; Brierley J; Cummings B; Zimmermann C; Dawson LA
    J Clin Oncol; 2013 Nov; 31(31):3980-6. PubMed ID: 24062394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Physician- and patient-reported symptom concordance and association with quality of life in hepatocellular carcinoma.
    Leith A; Kiiskinen U; Girvan AC; Jen MH; Khela K; Rider A; Massey L; Piercy J
    Future Oncol; 2022 Oct; 18(33):3727-3740. PubMed ID: 36377818
    [No Abstract]   [Full Text] [Related]  

  • 20. Health-related quality of life evaluated by tumor node metastasis staging system in patients with hepatocellular carcinoma.
    Qiao CX; Zhai XF; Ling CQ; Lang QB; Dong HJ; Liu Q; Li MD
    World J Gastroenterol; 2012 Jun; 18(21):2689-94. PubMed ID: 22690079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.